Search

Author/Creator Cheng, Min-Yi

3. Anthracycline-containing versus carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial. (April 2021)

Authors:
Gao, Hong-Fei; Wu, Zhiyong; Lin, Ying; Song, Xiang-Yang; Cao, Yin; Chen, Qian-Jun; Zhang, Gangling; Fu, Peifen; Liu, Zhenzhen; Zhang, Liu-Lu; Yang, Ci-Qiu; Yang, Mei; Zhu, Teng; Ji, Fei; Li, Jie-Qing; Cheng, Min-Yi; Wang, Kun
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis. (May 2022)

Authors:
Zhang, Liulu; Chen, Yuanqi; Cheng, Min-Yi; Zhuang, Xiaosheng; Zou, Jiachen; Wei, Dannuo; Lin, Ying-Yi; Zhang, Yi; Wang, Kun
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗